Virusbasierte Therapie schrumpft Tumoren bei Hautkrebspatienten
https://www.technologynetworks.com/tn/news/virus-based-therapy-shrinks-tumors-in-skin-cancer-patients-395441
Virusbasierte Therapie schrumpft Tumoren bei Hautkrebspatienten
https://www.technologynetworks.com/tn/news/virus-based-therapy-shrinks-tumors-in-skin-cancer-patients-395441
2 Kommentare
SS: TVEC, a genetically modified herpes simplex virus previously approved for treating superficial melanoma metastases, demonstrated promise in reducing tumor size and simplifying surgery. The study findings, published in *Nature Cancer*, reveal potential for the therapy to aid pre-surgical preparation for patients with challenging tumor locations.
Its called ‚Oncolytic Virus Therapy‘.
Its been an active area of research for quite some time but given cancer’s tendency to mutate its difficult to target with viruses that normally have very specific target receptors. Plus the body identifies the virus and eradicates it quite quickly.
Its not ready for primetime but with custom RNA based viruses, they could be be a great adjuvant for stubborn cancers. Give it another 10-15 years and I think we’ll see it regularly.